Saltar para:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Início > Publicações > Visualização > UPTAKE AND METABOLISM OF H-3 ADRENALINE AND H-3 NORADRENALINE BY ISOLATED HEPATOCYTES AND LIVER SLICES OF THE RAT

Publicações

UPTAKE AND METABOLISM OF H-3 ADRENALINE AND H-3 NORADRENALINE BY ISOLATED HEPATOCYTES AND LIVER SLICES OF THE RAT

Título
UPTAKE AND METABOLISM OF H-3 ADRENALINE AND H-3 NORADRENALINE BY ISOLATED HEPATOCYTES AND LIVER SLICES OF THE RAT
Tipo
Artigo em Revista Científica Internacional
Ano
1993
Autores
Martel, F
(Autor)
Outra
AZEVEDO, I
(Autor)
Outra
A pessoa não pertence à instituição. A pessoa não pertence à instituição. A pessoa não pertence à instituição. Sem AUTHENTICUS Sem ORCID
OSSWALD, W
(Autor)
Outra
A pessoa não pertence à instituição. A pessoa não pertence à instituição. A pessoa não pertence à instituição. Sem AUTHENTICUS Sem ORCID
Revista
Vol. 348
Páginas: 450-457
ISSN: 0028-1298
Editora: Springer Nature
Outras Informações
ID Authenticus: P-001-MHD
Abstract (EN): Isolated rat hepatocytes were incubated with 0.05 mumol/l or 0.2 mumol/l H-3-(-)-noradrenaline or 0.05 mumol/l H-3-(-)-adrenaline for 15 min and the content of amines as well as the formation of metabolites was measured. The removal of both amines from the incubation medium was quantitatively similar, and mainly due to metabolism (which represented 96% of the removal of H-3-adrenaline and 98% of the removal of H-3-noradrenaline). O-methylation predominated for H-3-adrenaline: O-methylated and deaminated metabolites (H-3-OMDA) and H-3-metanephrine (H-3-MN) were the most abundant metabolites, accounting for 63% and 34% of total metabolite formation, respectively. Deamination predominated for H-3-noradrenaline: H-3-OMDA and H-3-dihydroxymandelic acid (H-3-DOMA) were the most abundant metabolites, representing respectively 56% and 36% of total metabolite formation. The following activities of monoamine oxidase and catechol-O-methyl transferase were determined for H-3-noradrenaline: k(COMT) 0.70 +/- 0.15 min-1 and k(MAO) 2.27 +/- 0.14 min-1. In experiments with H-3-noradrenaline, inhibition of monoamine oxidase reduced the formation of H-3-OMDA and deaminated metabolites [H-3]-dihydroxyphenylglycol (H-3-DOPEG) and H-3-DOMA] and increased the formation of H-3-normetanephrine (H-3-NMN). Inhibition of catechol-O-methyl transferase, on the other hand, decreased H-3-NMN and increased H-3-DOPEG formation. When both enzymes were inhibited, the formation of all metabolites was strongly reduced but surprisingly there was no accumulation of H-3-amines in the cells, as the cell: medium ratio for H-3-noradrenaline or H-3-adrenaline was about unity. In experiments with either H-3-noradrenaline or H-3-adrenaline, specific inhibitors of either uptake1 or uptake2 produced discrete effects, slightly decreasing the formation of H-3-OMDA and H-3-NMN or H-3-MN, and having no effect on H-3-amine content of the cells. Additional experiments were carried out with mt liver slices incubated for 15 min with H-3-noradrenaline 0.2 mumol/l. The pattern of metabolism of H-3-noradrenaline (H-3-OMDA and H-3-DOMA were the most abundant metabolites) as well as the degree of metabolism of the amine removed from the incubation medium (91% of the removal) were similar to those of the isolated cells. Likewise, there was no accumulation of intact H-3-noradrenaline in the tissue. Moreover, the results obtained with enzyme inhibitors as wells as with uptake inhibitors were similar to those obtained with hepatocytes. In conclusion, isolated hepatocytes remove and metabolize catecholamines very efficiently, being one of the most active systems studied in this respect. Uptake1 and uptake2 are responsible for part of the removal of catecholamines by hepatocytes; the system(s) involved in the remaining removal seem(s) to be active, but possess(es) characteristics that do not allow us to characterize it (them) either as uptake, or uptake2.
Idioma: Inglês
Tipo (Avaliação Docente): Científica
Nº de páginas: 8
Documentos
Não foi encontrado nenhum documento associado à publicação.
Publicações Relacionadas

Dos mesmos autores

SUPEROXIDE-DISMUTASE PARTIALLY PREVENTS SYMPATHETIC DENERVATION BY 6-HYDROXYDOPAMINE (1991)
Artigo em Revista Científica Internacional
Albino Teixeira, A; AZEVEDO, I; Martel, F; OSSWALD, W
METABOLISM OF [H-3] NORADRENALINE BY UMBILICAL ARTERIES AND PLACENTAL BED TISSUE OBTAINED FROM NORMOTENSIVE AND PREECLAMPTIC HUMAN PREGNANCIES (1994)
Artigo em Revista Científica Internacional
FERREIRADEALMEIDA, JA; Martel, F; AZEVEDO, I; OSSWALD, W
EXTRANEURONAL UPTAKE AND O-METHYLATION OF H-3 ADRENALINE IN THE RABBIT AORTA (1993)
Artigo em Revista Científica Internacional
Martel, F; AZEVEDO, I; OSSWALD, W

Da mesma revista

TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications (2006)
Outra Publicação em Revista Científica Internacional
António Avelino Silva; Francisco Cruz
SYMPATHETIC DENERVATION CAUSES ATRIAL NATRIURETIC PEPTIDE-STORING GRANULES TO APPEAR IN THE VENTRICULAR MYOCARDIUM OF THE RAT (1990)
Outra Publicação em Revista Científica Internacional
Albino Teixeira, A; POLONIA, JJ; AZEVEDO, I
LONG-TERM ADMINISTRATION OF 1,3-DIPROPYL-8-SULPHOPHENYLXANTHINE (DPSPX) ALTERS ALPHA(2)-ADRENOCEPTOR-MEDIATED EFFECTS AT THE PREJUNCTIONAL BUT NOT AT THE POSTJUNCTIONAL LEVEL (1994)
Outra Publicação em Revista Científica Internacional
GUIMARAES, S; PAIVA, MQ; moura, d; Vaz Da Silva, M; Albino Teixeira, A
FUNCTIONAL CONSEQUENCES OF INHIBITION OF NUCLEOTIDE BREAKDOWN IN RAT VAS-DEFERENS - A STUDY WITH EVANS BLUE (1995)
Outra Publicação em Revista Científica Internacional
BULTMANN, R; DRIESSEN, B; GONCALVES, J; STARKE, K
Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling (2007)
Artigo em Revista Científica Internacional
Ana Patricia Fontes Sousa; Carmen Bras Silva; Ana Luisa Pires; Daniela Monteiro Sousa; Adelino F Leite Moreira

Ver todas (53)

Recomendar Página Voltar ao Topo
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Termos e Condições  I Acessibilidade  I Índice A-Z
Página gerada em: 2025-09-09 às 11:23:10 | Política de Privacidade | Política de Proteção de Dados Pessoais | Denúncias | Livro Amarelo Eletrónico